63 results
DEFA14A
AXLA
Axcella Health Inc.
3 Apr 20
Additional proxy soliciting materials
4:19pm
materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy … materials before voting. The proxy statement and annual report to stockholders are available at: www.investorvote.com/AXLA Easy Online Access — View
S-1/A
EX-10.10
AXLA
Axcella Health Inc.
30 Apr 19
IPO registration (amended)
6:06am
shall have the right of early access to the intended laboratory portion of the Leased Premises to perform LESSEE’S work therein as set forth … , as to which LESSEE shall be given access as contemplated below during LESSOR’S normal business hours for the purpose of reviewing and copying
DEFA14A
AXLA
Axcella Health Inc.
7 Apr 22
Additional proxy soliciting materials
4:00pm
presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all … Access — View your proxy materials and vote. When you go online, you can also help the environment by consenting to receive electronic delivery of future
DEFA14A
AXLA
Axcella Health Inc.
5 Apr 21
Additional proxy soliciting materials
4:18pm
. We encourage you to access and review all of the important information contained in the proxy materials before voting. The proxy statement and annual … report to stockholders are available at: www.investorvote.com/AXLA Easy Online Access — View your proxy materials and vote. Step 1:Go
8-K
EX-99.1
AXLA
Axcella Health Inc.
5 Aug 20
Axcella Reports Positive Top-Line Data from AXA1665-002 and Second Quarter Financial Results
8:22am
in a presentation that will be posted to “Investors & News” section of Axcella’s website prior to the call. Details about how to access this conference call … at www.axcellahealth.com in the Investors & News section. To access the call via telephone, please dial (866) 652-5200 (U.S. toll free) or (412) 317-6060
S-1/A
EX-10.2
csd16yc7u
30 Apr 19
IPO registration (amended)
6:06am
8-K
EX-99.1
e61iiyxlg8mi
30 Mar 22
Axcella Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
8:05am
8-K
EX-99.1
4eejq1d68me
29 Jul 21
Axcella Reports Second Quarter Financial Results and Provides Business Update
7:58am
8-K
EX-99.1
6w07if
6 May 21
Axcella Reports First Quarter Financial Results and Provides Business Update
7:51am
8-K
EX-99.1
oeoc4jo82m
6 May 20
Axcella Announces Positive Top-Line Data from AXA1125-003 Clinical Study Showing Multifactorial Activity in Adult Subjects with NAFLD
8:09am
DEF 14A
j8vhd3
3 Apr 20
Definitive proxy
4:15pm